लोड हो रहा है...

Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States

OBJECTIVES: The aim was to evaluate the cost-effectiveness of niraparib compared with routine surveillance (RS), olaparib and rucaparib for the maintenance treatment of patients with recurrent ovarian cancer (OC). METHODS: A decision-analytic model estimated the cost per quality-adjusted life-year (...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Pharmacoeconomics
मुख्य लेखकों: Guy, Holly, Walder, Lydia, Fisher, Mark
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer International Publishing 2018
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6386009/
https://ncbi.nlm.nih.gov/pubmed/30478649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-018-0745-z
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!